Top

Clinical Orthopaedics and Related Research®

Published in:

01-05-2017 | CORR Insights

CORR Insights^®: Are Readmissions After THA Preventable?

Author: Rajiv Gandhi, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 5/2017

Excerpt

Despite decades of data suggesting that preventing readmissions is extremely difficult [4, 5], both public and private payors are increasingly targeting readmission rates as a focus for quality improvement and cost savings. As the number of THAs performed in the United States continues to rise, so too, do the expenses associated with this intervention. Because of this, the Centers for Medicare & Medicaid Services (CMS) highlighted THA as a potential area of quality improvement and cost saving [3]. …

Avram V, Petruccelli D, Winemaker M, de Beer J. Total joint arthroplasty readmission rates and reasons for 30-Day hospital readmission. J Arthroplasty. 2014;29:465–468.CrossRefPubMed

Burke RE, Coleman EA. Interventions to decrease hospital readmissions. Keys for cost-effectiveness. JAMA Intern Med. 2013;173:695–698.CrossRefPubMed

Centers for Medicare & Medicaid Services. Readmissions reduction program. Available at: https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. Accessed November 8, 2016.

Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. N Eng J Med. 2010;363:2301–2309.CrossRef

Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to reduce 30-Day rehospitalization: A systematic review. Ann Intern Med. 2011;155:520–528.CrossRefPubMed

Husted H, Otte KS, Kristensen BB, Ørsnes T, Kehlet H. Readmissions after fasttrack hip and knee arthroplasty. Arch Orthop Trauma Surg. 2010;130:1185.CrossRefPubMed

Ibrahim MS, Alazzawi S, Nizam I, Haddad FS. An evidence-based review of enhanced recovery interventions in knee replacement surgery. Ann R Coll Surg Engl. 2013;95:386–389.CrossRefPubMedPubMedCentral

Joynt KE, Orav EJ, Jha AK. Thirty-day readmission rates for Medicare beneficiaries by race and site of care. JAMA. 2011;305:675–81.CrossRefPubMedPubMedCentral

Mednick RE, Alvi HM, Krishnan V, Lovecchio F, Manning DW. Factors affecting readmission rates following primary total hip arthroplasty. J Bone Joint Surg Am. 2014;96:1201–1209.CrossRefPubMed

10.

Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y. Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: Analysis from the ACS-NSQIP. J Arthroplasty. 2013;28:1499–1504.

11.

Sibia US, Mandelblatt AE, Callanan MA, MacDonald JH, King PJ. Incidence, risk factors, and costs for hospital returns after total joint arthroplasties. J Arthroplasty. [Published online ahead of print August 12, 2016]. DOI: 10.1016/j.arth.2016.08.003.

12.

Stambough JB, Nunley RM, Curry MC, Steger-May K, Clohisy JC. Rapid recovery protocols for primary total hip arthroplasty can safely reduce length of stay without increasing readmissions. J Arthroplasty 2015;30:521.CrossRefPubMedPubMedCentral

13.

van Walraven C, Jennings A, Taljaard M, Dhalla I, English S, Mulpuru S, Blecker S, Forster AJ. Incidence of potentially avoidable urgent readmissions and their relation to all-cause urgent readmissions. CMAJ. 2011;183:1067–1072.CrossRef

14.

Williams J, Kester BS, Bosco JA, Slover JD, Iorio R, Schwarzkopf R. The association between hospital length of stay and 90-Day readmission risk within a total joint arthroplasty bundled payment initiative. J Arthroplasty. 2016;31:2741–2745.CrossRefPubMed

Title: CORR Insights®: Are Readmissions After THA Preventable?
Author: Rajiv Gandhi, MD
Publication date: 01-05-2017
Publisher: Springer US
Published in: Clinical Orthopaedics and Related Research® / Issue 5/2017
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-016-5190-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

CORR Insights^®: Are Readmissions After THA Preventable?

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2017

Is Pes Cavus Alignment Associated With Lisfranc Injuries of the Foot?

Pearls: Patient-generated Pain Drawings

Medicolegal Sidebar: Expanding Hospital Liability—The Concept of Willful Blindness

Can Spatiotemporal Fluoride (18F−) Uptake be Used to Assess Bone Formation in the Tibia? A Longitudinal Study Using PET/CT

Classifications In Brief: American Spinal Injury Association (ASIA) Impairment Scale

Editor’s Spotlight/Take 5: Patients With Limited Health Literacy Ask Fewer Questions During Office Visits With Hand Surgeons